Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gottwik

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Zeitschrift Fur Kardiologie|August 7, 2001
[Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct]H Wienbergen, R Schiele, A K Gitt, et al.
Heart (British Cardiac Society)|August 1, 2007
Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)R Zahn, M Gottwik, M Hochadel, et al.
Deutsche Medizinische Wochenschrift (1946)|October 27, 1999
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]M Gottwik, R Kretschmar, A Vogt, et al.
Journal of the American College of Cardiology|December 29, 2000
Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)R Zahn, R Schiele, S Schneider, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 1999
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study GroupR Zahn, S Schuster, R Schiele, et al.
Heart (British Cardiac Society)|July 16, 2005
In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer KrankenhausarzteR Zahn, A Vogt, U Zeymer, et al.
Zeitschrift Fur Kardiologie|April 20, 2002
[Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial]R Zhan, R Schiele, S Schneider, et al.
Zeitschrift Fur Kardiologie|February 25, 2014
[Not Available]Birgit Frilling, R Schiele, R Zahn, et al.
Zeitschrift Fur Kardiologie|April 20, 2002
[Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries]B Frilling, R Schiele, R Zahn, et al.
Zeitschrift Fur Kardiologie|April 15, 2003
[A statement about guidelines on pacemaker therapy]B Lemke, K Ryback, U Wiegand, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Zeitschrift Fur Kardiologie|August 7, 2001
[Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct]H Wienbergen, R Schiele, A K Gitt, et al.
Heart (British Cardiac Society)|August 1, 2007
Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)R Zahn, M Gottwik, M Hochadel, et al.
Deutsche Medizinische Wochenschrift (1946)|October 27, 1999
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]M Gottwik, R Kretschmar, A Vogt, et al.
Journal of the American College of Cardiology|December 29, 2000
Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)R Zahn, R Schiele, S Schneider, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 1999
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study GroupR Zahn, S Schuster, R Schiele, et al.
Heart (British Cardiac Society)|July 16, 2005
In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer KrankenhausarzteR Zahn, A Vogt, U Zeymer, et al.
Zeitschrift Fur Kardiologie|April 20, 2002
[Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial]R Zhan, R Schiele, S Schneider, et al.
Zeitschrift Fur Kardiologie|February 25, 2014
[Not Available]Birgit Frilling, R Schiele, R Zahn, et al.
Zeitschrift Fur Kardiologie|April 20, 2002
[Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries]B Frilling, R Schiele, R Zahn, et al.
Zeitschrift Fur Kardiologie|April 15, 2003
[A statement about guidelines on pacemaker therapy]B Lemke, K Ryback, U Wiegand, et al.
Pageof 8